| Name | CD2_INSITU_OTHER_NOS |
|---|---|
| Long name | Carcinoma in situ of other and unspecified sites |
| Hospital Discharge registry | ICD-10: D09 |
| Cause of Death registry | ICD-10: D09 |
| Include | CD2_INSITU_BLADDER, CD2_INSITU_URINARY_NOS, CD2_INSITU_EYE, CD2_INSITU_THYROICD2_ENDOCRINE, CD2_INSITU_NOS |
| Level in the ICD-hierarchy | 2 |
| First defined in version | DF2 |
| Latin name | Carcinoma in situ locis aliis sive non specificatis |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 52 | 20 | 32 |
| Unadjusted prevalence (%) | 0.02 | 0.02 | 0.03 |
| Mean age at first event (years) | 62.95 | 54.09 | 68.49 |
| Case fatality at 5-years (%) | 17.31 | 15.00 | 18.75 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.5 |
| Recurrence at 6 months (%) | 34.62 | 25.00 | 40.63 |
before Carcinoma in situ of other and unspecified sites
after Carcinoma in situ of other and unspecified sites
Loading survival analyses plot…
Loading survival analyses table…